Krynica Vitamin SA (KVT) - Net Assets
Based on the latest financial reports, Krynica Vitamin SA (KVT) has net assets worth zł102.98 Million PLN (≈ $28.34 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł207.21 Million ≈ $57.03 Million USD) and total liabilities (zł104.22 Million ≈ $28.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Krynica Vitamin SA liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł102.98 Million |
| % of Total Assets | 49.7% |
| Annual Growth Rate | 9.29% |
| 5-Year Change | 11.2% |
| 10-Year Change | 55.1% |
| Growth Volatility | 21.87 |
Krynica Vitamin SA - Net Assets Trend (2012–2024)
This chart illustrates how Krynica Vitamin SA's net assets have evolved over time, based on quarterly financial data. Also explore how large is Krynica Vitamin SA's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Krynica Vitamin SA (2012–2024)
The table below shows the annual net assets of Krynica Vitamin SA from 2012 to 2024. For live valuation and market cap data, see Krynica Vitamin SA (KVT) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł94.03 Million ≈ $25.88 Million |
+14.95% |
| 2023-12-31 | zł81.80 Million ≈ $22.51 Million |
-10.04% |
| 2022-12-31 | zł90.93 Million ≈ $25.03 Million |
+16.80% |
| 2021-12-31 | zł77.85 Million ≈ $21.43 Million |
-7.94% |
| 2020-12-31 | zł84.56 Million ≈ $23.27 Million |
+53.64% |
| 2019-12-31 | zł55.04 Million ≈ $15.15 Million |
-1.76% |
| 2018-12-31 | zł56.03 Million ≈ $15.42 Million |
+2.98% |
| 2017-12-31 | zł54.41 Million ≈ $14.97 Million |
+3.84% |
| 2016-12-31 | zł52.40 Million ≈ $14.42 Million |
-13.57% |
| 2015-12-31 | zł60.62 Million ≈ $16.68 Million |
+57.13% |
| 2014-12-31 | zł38.58 Million ≈ $10.62 Million |
+3.99% |
| 2013-12-31 | zł37.10 Million ≈ $10.21 Million |
+14.53% |
| 2012-12-31 | zł32.40 Million ≈ $8.92 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Krynica Vitamin SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 112.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł12.23 Million | 13.01% |
| Common Stock | zł18.38 Million | 19.54% |
| Other Components | zł63.42 Million | 67.45% |
| Total Equity | zł94.03 Million | 100.00% |
Krynica Vitamin SA Competitors by Market Cap
The table below lists competitors of Krynica Vitamin SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Silver Viper Minerals Corp
V:VIPR
|
$42.83 Million |
|
Emami Realty Limited
NSE:EMAMIREAL
|
$42.84 Million |
|
Cengild Medical Berhad
KLSE:0243
|
$42.87 Million |
|
AXIOS Sustainable Growth
NYSE:AXAC
|
$42.88 Million |
|
Marketwise Inc
NASDAQ:MKTW
|
$42.82 Million |
|
Gunpoint Exploration Ltd
V:GUN
|
$42.80 Million |
|
Mereo BioPharma Group plc
F:MAH0
|
$42.79 Million |
|
Abocom Systems Inc
TW:2444
|
$42.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Krynica Vitamin SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 81,800,000 to 94,031,000, a change of 12,231,000 (15.0%).
- Net income of 12,231,000 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł12.23 Million | +13.01% |
| Total Change | zł- | 14.95% |
Book Value vs Market Value Analysis
This analysis compares Krynica Vitamin SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.65x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 67.00x to 1.65x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | zł0.19 | zł12.70 | x |
| 2013-12-31 | zł0.22 | zł12.70 | x |
| 2014-12-31 | zł0.23 | zł12.70 | x |
| 2015-12-31 | zł4.95 | zł12.70 | x |
| 2016-12-31 | zł4.28 | zł12.70 | x |
| 2017-12-31 | zł4.44 | zł12.70 | x |
| 2018-12-31 | zł4.57 | zł12.70 | x |
| 2019-12-31 | zł4.49 | zł12.70 | x |
| 2020-12-31 | zł6.57 | zł12.70 | x |
| 2021-12-31 | zł6.35 | zł12.70 | x |
| 2022-12-31 | zł7.42 | zł12.70 | x |
| 2023-12-31 | zł6.68 | zł12.70 | x |
| 2024-12-31 | zł7.67 | zł12.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Krynica Vitamin SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.01%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.15%
- • Asset Turnover: 1.73x
- • Equity Multiplier: 2.39x
- Recent ROE (13.01%) is below the historical average (16.99%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 8.78% | 2.70% | 1.39x | 2.34x | zł-394.60K |
| 2013 | 11.68% | 3.26% | 1.50x | 2.38x | zł624.80K |
| 2014 | 31.29% | 7.23% | 1.82x | 2.38x | zł8.21 Million |
| 2015 | 22.37% | 8.20% | 1.54x | 1.77x | zł7.50 Million |
| 2016 | 4.88% | 1.53% | 1.35x | 2.36x | zł-2.68 Million |
| 2017 | 10.56% | 2.78% | 1.55x | 2.45x | zł305.20K |
| 2018 | 9.01% | 1.88% | 1.78x | 2.70x | zł-552.80K |
| 2019 | 12.83% | 2.38% | 1.72x | 3.13x | zł1.56 Million |
| 2020 | 70.28% | 12.69% | 2.12x | 2.61x | zł48.55 Million |
| 2021 | 20.01% | 3.94% | 1.74x | 2.92x | zł7.79 Million |
| 2022 | 14.38% | 3.47% | 1.62x | 2.56x | zł3.99 Million |
| 2023 | -8.17% | -1.86% | 1.58x | 2.78x | zł-14.86 Million |
| 2024 | 13.01% | 3.15% | 1.73x | 2.39x | zł2.83 Million |
Industry Comparison
This section compares Krynica Vitamin SA's net assets metrics with peer companies in the Beverages - Non-Alcoholic industry.
No peer company data available for comparison.
About Krynica Vitamin SA
Krynica Vitamin S.A. produces and sells non-alcoholic and low-alcoholic beverages in Poland, Germany, the United Kingdom, the Czech Republic, Slovakia, and internationally. It offers energy drink; functional drinks, such as vitamin cocktails, beverage with day and night formulas, and diet supplements; carbonated soft drink includes cola type, orange type, and lemon type beverages; alcopops; coffe… Read more